Physical Address
304 North Cardinal St.
Dorchester Center, MA 02124
Pancreatic Ductal Adenocarcinoma (PDAC) is often described as an “intractable” disease, a term that speaks to its profound resistance to treatment. But this label, while accurate, is incomplete. It paints a picture of a homogenous, indestructible enemy. A more novel…
In the grim lexicon of pancreatic cancer, one term casts a long, dark shadow: Pancreatic Ductal Adenocarcinoma (PDAC). It is the relentless juggernaut, the silent killer that dominates over 90% of diagnoses and dictates the narrative of despair. Lurking in…
Diagnosing pancreatic acinar cell carcinoma (ACC) is less a linear clinical pathway and more a complex detective story. The initial clues are often frustratingly vague—abdominal pain, weight loss, or occasionally, a distinctive paraneoplastic syndrome characterized by polyarthralgia and eosinophilia due…
The prognosis for pancreatic acinar cell carcinoma (ACC) has long been viewed through a grim, monolithic lens, often conflated with its notoriously aggressive cousin, pancreatic ductal adenocarcinoma (PDAC). Traditional statistics, citing a five-year survival rate hovering between 25-50% for resectable…
To ask for the “best” treatment for pancreatic acinar cell carcinoma (ACC) is to pose a question with a moving target. In the world of oncology, “best” is rarely a single, universally applicable protocol, but for a rare and enigmatic…
When we speak of pancreatic cancer, the mind often conjures a grim, well-defined portrait: painless jaundice, a silent killer discovered too late. This narrative, while tragically accurate for the more common pancreatic ductal adenocarcinoma (PDAC), dangerously obscures the unique and…
A cancer tissue microarray (TMA) is, at its core, an exercise in efficient pathology. But when it is infused with robust clinical annotations, it undergoes a profound metamorphosis. It ceases to be a mere collection of biological samples and evolves…
In the quiet archives of constant temperature and humidity in pathology departments all over the world, countless paraffin-embedded tissue blocks lie there quietly. They are not ordinary specimens, but biological “time capsules”, each of which solidifies a moment in the…
In the grand narrative of medical science, common diseases are like well-documented historical periods. We have rich cultural relics and extensive literature, and have a clear understanding of its social impact. Studying breast cancer or lung cancer is like studying…
In the vast and chaotic oncology universe, hepatocellular carcinoma (HCC) is as complicated as a nebula. It is not a single disease, but a galaxy composed of various heterogeneous malignant tumors, each of which has its own unique gene mutation,…
